Hypertension is a leading cause of morbidity and mortality in the African-American population. Current data on the epidemiology, pathophysiology, and target organ damage in the hypertensive African-American population are reviewed. The implications of these racial differences for management are discussed, and the recommendations for drug therapy in this high-risk population are proposed.